版本:
中国

BRIEF-Ampliphi Biosciences Q1 loss per share $1.94

May 15 Ampliphi Biosciences Corp

* Ampliphi Biosciences reports first quarter 2017 financial results and provides business highlights

* Q1 loss per share $1.94

* Ampliphi Biosciences Corp - Cash and cash equivalents were $2.2 million as of March 31, 2017, compared with $5.7 million as of December 31, 2016

* Ampliphi Biosciences Corp - Ampliphi recorded a gain for Q1 of 2017 of $114,000 related to change in fair value of derivative liabilities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐